FindTrial
Sign In

Effect of plastics on polycystic ovarian syndrome

Elucidation of molecular pathomechanisms of plasticizer in the polycystic ovarian syndrome. - PCOS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/08/015165
Enrollment
300
Registered
2018-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

Dr Padmalatha S Rai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Those who have attained menarche. Clinically diagnosed Polycystic Ovarian Syndrome patients based on Rotterdam diagnostic criteria (2003) will be recruited.

Exclusion criteria

Exclusion criteria: Females in the age group 45 years. Those who have not attained menarche. Patients diagnosed of suffering from any chronic illness except Diabetes mellitus. Those who have attained menopause.

Design outcomes

Primary

MeasureTime frame
This study will help us to identify novel sequence variations that influence susceptibility to Bisphenol A induced Polycystic ovarian syndrome. Genetic variations are population specific and this study can generate exposure biomarker for BPA and PCOS susceptibility.Timepoint: 3 years—

Secondary

MeasureTime frame
Screening target populations may provide opportunity for promoting healthy lifestyles and early interventions to prevent future morbidities.Timepoint: 3 years—

Countries

India

Contacts

Public ContactDr Guruprasad K P

School of Life Sciences, Manipal Academy of Higher Education, Manipal

padmalatha.rai@manipal.edu9448215768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026